Streetbeat News

Stock Prices

MAR

Marriott Intl's (NYSE:MAR) short interest has decreased by 5.03% since the last report, with 6.28 million shares sold short, representing 2.83% of available shares. The average time to cover these short positions is 4.59 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Marriott has a lower short interest compared to its peer group average of 6.48%.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:15 pm

CAVA

Cava Group (NYSE:CAVA) has seen a 26.01% decrease in short interest since its last report, with 9.59 million shares sold short, representing 8.76% of its float. The average time to cover these short positions is 4.47 days. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price. Cava Group's short interest is slightly higher than its peer group average of 8.42%.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:15 pm

PBLA

Panbela Therapeutics (NYSE:PBLA) has seen a significant increase in short interest, with the short percent of float rising 912.95% to 14.08% of available shares. It would take about 1.0 days to cover all short positions. While high short interest can indicate bearish sentiment, it doesn't necessarily predict a price drop. Panbela's short interest is higher than its peer group average of 4.23%.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:15 pm

HUT

Hut 8 (NASDAQ:HUT) has refuted allegations by J Capital Research, which accused the company of overpaying for the merger with US Bitcoin Corp (USBTC) and claimed USBTC was near bankruptcy. J Capital, holding short positions in Hut 8, suggested the merger was a pump-and-dump scheme. Hut 8's shares dropped 23.3% following the report. Hut 8 defended its merger, financial health, and diversified revenue streams, stating it holds 9,195 Bitcoin worth approximately $390 million. The company criticized the report as inaccurate and self-serving for the short seller.

Portfolio Pulse from Neil Dennis

January 24, 2024 | 5:15 pm

BNTC

JMP Securities analyst Silvan Tuerkcan has maintained a Market Outperform rating on Benitec Biopharma (NASDAQ:BNTC) and increased the price target from $6 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:14 pm

XP

XP Inc. shares are experiencing an uptick following an upgrade from Neutral to Outperform by Banco Bradesco BBI S.A, which also set a price target of $32 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:11 pm

BTCUSD

Despite Bitcoin's (BTC) recent dip below $40,000, technical analysts remain optimistic about an upcoming rebound. The cryptocurrency experienced a 10% drop from highs near $48,000, but analysts like Ali Charts and CryptoDonAlt view the pullback as temporary, citing the 'Sentiment Cycle' and a bullish chart pattern. While opinions vary, with some expecting further declines, others, including ARK Invest CEO Cathie Wood, are bullish on Bitcoin's long-term prospects, especially with the upcoming Bitcoin halving event.

Portfolio Pulse from Khyathi Dalal

January 24, 2024 | 5:10 pm

ABT

Abbott Laboratories' stock is trading lower following the release of their Q4 financial results and the company's future guidance.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:09 pm

APH

Amphenol Corporation's stock is trading higher following the announcement of their Q4 financial results, which surpassed expectations. The company also provided positive guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:08 pm

GD

General Dynamics (GD) stock is trading higher following the announcement of Q4 sales results that surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:07 pm